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Abstract
VKORC1 (vitamin K epoxide reductase complex subunit 1, 16p11.2) is the main genetic determinant of human response to
oral anticoagulants of antivitamin K type (AVK). This gene was recently suggested to be a putative target of positive
selection in East Asian populations. In this study, we genotyped the HGDP-CEPH Panel for six VKORC1 SNPs and downloaded
chromosome 16 genotypes from the HGDP-CEPH database in order to characterize the geographic distribution of footprints
of positive selection within and around this locus. A unique VKORC1 haplotype carrying the promoter mutation associated
with AVK sensitivity showed especially high frequencies in all the 17 HGDP-CEPH East Asian population samples. VKORC1
and 24 neighboring genes were found to lie in a 505 kb region of strong linkage disequilibrium in these populations.
Patterns of allele frequency differentiation and haplotype structure suggest that this genomic region has been submitted to
a near complete selective sweep in all East Asian populations and only in this geographic area. The most extreme scores of
the different selection tests are found within a smaller 45 kb region that contains VKORC1 and three other genes (BCKDK,
MYST1 (KAT8), and PRSS8) with different functions. Because of the strong linkage disequilibrium, it is not possible to
determine if VKORC1 or one of the three other genes is the target of this strong positive selection that could explain
present-day differences among human populations in AVK dose requirement. Our results show that the extended region
surrounding a presumable single target of positive selection should be analyzed for genetic variation in a wide range of
genetically diverse populations in order to account for other neighboring and confounding selective events and the
hitchhiking effect.
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Introduction
Oral anticoagulants of antivitamin K type (AVK) 2 such as
warfarin and acenocoumarol 2 are widely prescribed drugs for
the prevention and treatment of arterial and venous thromboem-
bolic disorders [1,2]. They exert their anticoagulant effect by
inhibiting the vitamin K 2,3-epoxide reductase complex 1
(VKORC1). Besides well-known physiopathological and environ-
mental factors, including age, sex, body mass index, disease states,
co-medications and diet, genetic factors have been identified as
major determinants of AVK dose variability [3]. Candidate-gene
and genome-wide association studies have identified four main
genes 2 CYP2C9, CYP4F2, CYP2C18 and VKORC12 which
explain together between 28.2% and 43.5% of the AVK dose
variance [3,4,5,6,7]. CYP2C9, CYP4F2 and CYP2C18 encode
proteins involved in the hepatic metabolism of AVK [8,9,10].
VKORC1 encodes the VKORC1 enzyme, which is the direct
pharmacologic target of AVK [11,12]. Differences in the
worldwide distribution of the most important polymorphisms
influencing AVK dosing are likely to underlie the wide interethnic
variability in AVK dose requirements: current population-based
trends in warfarin dosing, as reported by the International
Warfarin Pharmacogenetics Consortium, indicate a mean weekly
dose of 21 mg in Asians, 31.5 mg in Europeans and 40 mg in
individuals of African ancestry [13].
Recently, Ross et al. [14] documented the distribution of four
functional variants located in the three main genes known to
influence AVK dose requirement 2 rs9923231 (VKORC1),
rs1799853 and rs1057910 (CYP2C9), and rs2108622 (CYP4F2) 2
in a large set of samples from the Human Genome Diversity
Project - Centre d’Etude du Polymorphisme Humain (HGDP-
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CEPH) Panel, representing 52 world populations [15]. They
observed a pattern of genetic differentiation among human
populations for the VKORC1 single nucleotide polymorphism
(SNP) rs9923231. They applied three formal tests of positive
selection to the VKORC1 gene 2 the locus-specific branch length
(LSBL) test [16], the log of the ratio of heterozygosities (lnRH) test
[17], and Tajima’s D [18] 2 using genome-wide data available for
the West African, European and East Asian HapMap samples
[19]. The tests yielded significant results in the East Asian sample.
Interestingly, the rs9923231 SNP (g.-1639G.A), which was found
to be a putative target of positive selection [14], is the main genetic
determinant of AVK dose requirement and can alone explain
between 25% to 30% of the dose variance among patients
[4,5,6,7]. This SNP, located in the promoter region, alters a
VKORC1 transcription factor binding site, leading to lower protein
expression [20]. By decreasing VKORC1 activity, the derived -
1639A allele thus confers an increased AVK sensitivity phenotype
and patients carrying one and two -1639A alleles require on
average respectively 25% and 50% lower daily warfarin doses than
-1639G homozygous carriers to obtain the same anticoagulant
effect [21,22]. Understanding the processes of local adaption that
may result in high levels of population differentiation and
important interethnic differences in the required AVK dose is
thus of particular relevance.
During these last few years, newer methods than those proposed
by Ross et al. have been developed to detect the molecular
footprints of positive selection. These methods are particularly well
suited to detect classical signatures of selective sweeps, i.e. when a
new advantageous mutation spreads rapidly to fixation in
particular populations (the so-called ‘hard sweep’ model) [23].
Such a selective sweep occurs too quickly to leave enough time for
recombination events to break down the linkage disequilibrium
(LD), leading to a similar increase in frequency of alleles at nearby
variants. Therefore, the pattern of genetic variation in the genomic
region surrounding the selected allele may differ among popula-
tions [24], and the selected allele is expected to be carried by a
long and frequent haplotype only in those populations that
experienced the local adaptive event [25]. Signals of positive
selection can thus be detected by looking for an increased genetic
differentiation among populations (using methods such as FST [26]
and the Cross-Population Composite Likelihood Ratio (XP-CLR)
test [24]), and an extended haplotype homozygosity (EHH) at the
putatively selected locus (using methods such as the Cross-
Population Extended Haplotype Homozygosity (XP-EHH) test
[27] and the integrated Haplotype Score (iHS) [28]). These
methods have proved to be powerful and largely complementary
to detect and localize a selective sweep, and are more robust to
ascertainment bias in SNP discovery than methods based on the
allele frequency spectrum such as the Tajima’s D used by Ross
et al. [14,29].
In this study, we investigated whether and how positive selection
has acted on the VKORC1 gene locus using these complementary
analytic methods. Our first objective was to determine (1) if the
selective sweep is restricted to East Asia or if it is detected in other
geographic regions, in particular Central South Asia and America,
which are geographically close to East Asia, and (2) if it occurred in
all East Asian populations or only in a few of them. Thus, we
genotyped six VKORC1 SNPs in the HGDP-CEPH Panel [30]
which covers a much wider range of world populations – including
17 populations from East Asia – than the HapMap Panel in which
positive selection at the VKORC1 locus was initially evidenced.
Furthermore, by expanding the analysis to a 2 Mb region
encompassing the VKORC1 gene, we sought to determine if the
selective sweep identified around VKORC1 was due to positive
selection directly acting on this gene, or if it was caused by positive
selection at a nearby linked gene resulting in genetic hitchhiking
[23]. Finally, we discuss combining different methods for
uncovering distinct selection signatures, in order to both increase
power to detect a selective signal and precisely define its genomic
location. We address the difficulty, even with such detailed
analyses, in identifying the specific target of selection.
Results
VKORC1 Haplotype Study
A haplotype study of the 4.1 kb VKORC1 gene was carried out
with seven VKORC1 SNPs genotyped in the 52 HGDP-CEPH
population samples (Figure 1A). Haplotypes were reconstructed
from these SNPs. Seven of these haplotypes had a frequency above
1% in at least one geographic region and were labeled H1 to H7
according to their frequency at the global level (Figure 1B). Four
haplotypes are found in at least five geographic regions and only
two are shared among all regions. The highest and lowest
haplotype diversity values are observed in Sub-Saharan Africa
(0.7560.02) and East Asia (0.1960.02), respectively. Most
individuals carrying the ancestral haplotype (H6), i.e. the haplotype
carrying the ancestral allele at each SNP, are from Sub-Saharan
Africa (Figure 1B and Figure S1). Interestingly, the -1639A allele
(rs9923231) conferring the increased sensitivity to AVK is carried
by a unique haplotype (H1). This haplotype associated with AVK
sensitivity is the most frequent at the worldwide level (49.7%) and
shows an extremely high differentiation among geographic regions
(Figure 1B). While rare in Sub-Saharan Africa (4.4%), it is found at
intermediate frequencies in the Middle East, Europe, Central
South Asia, Oceania and America (from 27.8% to 51.2%), and is
largely predominant in East Asia (89.6%). The prevalence of H1
tends to be high in all of the 17 East Asian population samples
investigated, ranging from 75% in She to 100% in Oroqen (Figure
S1). However, the sample size is small for most of them, with 10 or
less individuals.
The median-joining haplotype network describes the mutational
relationships between the different VKORC1 haplotypes inferred
(Figure 1C). Haplotype H1 differs from the others by two
nucleotide substitutions at the functional rs9923231 SNP and at
the rs9934438 SNP, which are found in complete LD in all
geographic regions (D’ = 1 and r2 = 1, Figure S2).
Detection of Signatures of Positive Selection
To support the hypothesis that positive selection has played a
role in shaping patterns of genetic variation at VKORC1, four
complementary methods were applied to detect signatures of
selective sweeps in the genome. FST and XP-CLR are both based
on allele frequency differentiation, whereas XP-EHH and iHS are
based on haplotype structure. Scores for the four test statistics were
computed at both the regional and population levels for the seven
VKORC1 SNPs and for some other available SNPs [15]
representing the expected neutral genomic background. For each
score, a p-value was derived from the empirical distribution
obtained from the genomic background (cf. Material and
Methods). We considered as significant any p-value below 0.05.
The results of the four tests are presented in Table 1 and Table 2.
At the global level, when we evaluated the level of genetic
differentiation among the seven HGDP-CEPH Panel geographic
regions, an atypical pattern of genetic differentiation was detected
for four VKORC1 SNPs: rs2359612, rs8050894, rs9934438 and
rs9923231 (p,0.05). The functional rs9923231 polymorphism and
the rs9934438 SNP, in complete LD with each other, displayed
FST values falling above the 99
th percentile of the empirical
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genome-wide distribution (FST=0.32, p=0.008) (Figure 2A).
When global FST values were computed among the 52 world
populations, very similar results were obtained (Table S1). At the
inter-regional level, i.e. between a given geographic region and the
remaining ones, the same four VKORC1 SNPs showed highly
significant FST values (p,0.01) when comparing Central South
Asia and East Asia to the rest of the world (Table 1, Figures 2B
and 2C). Regarding East Asia, the highest FST values (FST=0.41,
p=0.003) were also observed for the two SNPs, rs9923231 and
rs9934438. For the other geographic regions, no VKORC1 SNP
displayed an inter-regional FST value as much significant as the
ones observed for Central South Asia and East Asia (Table 1 and
Figure S3). At the intra-regional level, i.e. among populations
within a region, no extreme pattern of genetic differentiation
(p,0.01) was observed for any VKORC1 SNP in any geographic
region (Table 1 and Figure S4).
The XP-CLR test applied to each geographic region also
provided evidence of an atypical pattern of genetic differentiation
at the VKORC1 gene locus, with XP-CLR scores in East Asia
ranging from 16.53 (p=0.050) to 43.44 (p=0.012) in the 16 kb
genomic region centered on VKORC1 (Table 2). For each of the
other six geographic regions, the XP-CLR scores were very low,
supporting the existence of a selective sweep restricted to East
Asia. In this geographic region, when the XP-CLR test was
Figure 1. Results of the VKORC1 haplotype study. (A) Position of the seven SNPs along the VKORC1 gene. VKORC1 is a 4.1 kb gene
(GenBank accession number AY587020) located at 16p11.2. The three exons of the gene are represented as boxes, with 59UTR and 39UTR regions
colored in grey and coding regions in black. Flanking and intronic regions are represented as thin and thick lines, respectively. The seven studied
SNPs are shown in their sequential order along the VKORC1 gene. The functional polymorphism rs9923231 located in the promoter, is highlighted in
red and the SNP already present in the Illumina 650K chip in blue. Physical position along chromosome 16 is indicated in kb below. (B) Distribution
of VKORC1 haplotypes at the global and regional level. For each haplotype, SNPs are listed in the same sequential order than in Figure 1A.
Ancestral and derived alleles are shown in blue and orange, respectively. Haplotype labels H1 to H7 were given according to the global haplotype
frequency. AF, sub-Saharan Africa; ME, Middle East; EUR, Europe; CSA, Central South Asia; EA, East Asia; OCE, Oceania; AM, America. (C) Median-
joining network of the inferred VKORC1 haplotypes at the global level. Circles areas are proportional to the global haplotype frequency and
branch lengths to the number of mutations separating haplotypes. Labels of haplotypes are indicated in corresponding circles, and labels of
mutations on the network branches. The haplotype carrying the -1639A allele conferring the AVK sensitivity phenotype (H1) is shown in red and the
ancestral haplotype (H6) in black.
doi:10.1371/journal.pone.0053049.g001
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performed for each population, all of the 17 population samples,
except Oroqen, showed this extreme pattern of genetic differen-
tiation, with at least three significant XP-CLR scores out of the five
scores computed in the 16 kb genomic region surrounding
VKORC1 (Table S2). As most of the SNPs in the VKORC1
genomic region have reached fixation in the Oroqen sample, XP-
CLR scores could be calculated for only very few SNPs on either
side of VKORC1, making difficult the interpretation of XP-CLR
results in this sample.
Regional results obtained with the extended haplotype-based
XP-EHH test indicated that the unusual pattern of genetic
differentiation observed at the VKORC1 gene locus resulted from a
selective sweep in East Asia. Significant XP-EHH scores, ranging
from 2.68 (p=0.011) to 3.10 (p=0.005), were observed for the
seven VKORC1 SNPs in East Asia, while no significant values were
observed for any other geographic region (Table 1). For East Asian
populations, evidence for a selective sweep was detected in all 17
population samples with significant XP-EHH scores for each of
the seven VKORC1 SNPs, ranging from 1.84 (p=0. 049) in the Dai
sample for rs7294, to 3.78 (p=0.004) in the Tujia sample for
rs8050894 (Table S3).
With the iHS test, only two VKORC1 SNPs (rs7294 and
rs2359612) exhibited significant iHS scores in East Asia (p = 0.040
and 0.047, respectively; Table 1). Two other significant scores
were observed for the rs2359612 SNP in the Middle East (2.69,
p = 0.009) and Europe (2.00, p=0.039). At the population level in
East Asia, only three samples (Hezhen, Lahu, and Yakut)
displayed significant iHS scores for two, three and four SNPs,
respectively (Table S3).
The four selection tests consistently evidenced the signature of a
selective sweep involving the VKORC1 genomic region in East
Asia. However, this result did not allow us to determine with
certainty that VKORC1 is the direct target of positive selection. A
linked gene could be the target instead, resulting in genetic
hitchhiking of VKORC1 [23]. In an attempt to seek the true target
of positive selection, we probed the downloaded chromosome 16
genotypes [15] with the four tests for selection and examined the
results over an extended 2 Mb genomic region centered on
VKORC1. We focused on clusters of selection test scores with
highly significant p-values (p,0.01) for East Asia only. Three
clusters were observed (Figure 3): (i) , 570 kb downstream of
VKORC1, the first cluster was found with partially overlapping
clusters of extreme XP-CLR and XP-EHH scores over a region of
64 and 39 kb, respectively, involving the genes ITGAL, ZNF768,
and ZNF747; (ii) at or close to VKORC1 genomic position, the
second cluster was determined by overlapping clusters of extreme
FST values when comparing East Asia to the rest of the world (with
the lowest p-values observed for the same two VKORC1 SNPs
evidenced before, rs9923231 and rs9934438) and extreme XP-
CLR and XP-EHH scores. These clusters ranged in size from 45
to 244 kb; (iii) , 230 kb upstream of VKORC1, the third cluster of
32 kb was found with XP-EHH and concerned the genes ITGAM
and ITGAX. If SNPs within clusters are in high LD (D’$0.97,
except for one SNP in the third cluster), only limited LD exists
between the SNPs located in the different clusters (Figure 4 and
Figure S5) and several recombination hotspots are present
between these clusters (Figure 4). This suggests that each of the
three clusters represents a different adaptive event.
Examination of the second cluster showed that VKORC1 is
contained in a block of strong LD spanning , 505 kb in East Asia
(Figure 4 and Figure S5). Similar LD blocks were observed for
Central South Asia and Europe, and to a lesser extent, for the
Middle East (Figure S5). This LD block encompasses 25 genes
(Figure 4). We used the most extreme FST, XP-CLR and XP-EHH
scores in order to spatially localize a target of selection within the
LD block. Significant XP-CLR scores (p,0.05) were found in a
350 kb region encompassing 19 genes including VKORC1 (Table
S4). XP-EHH scores were almost all significant at the 0.05
threshold but four adjacent genes VKORC1, BCKDK, MYST1
(KAT8) and PRSS8 displayed most extreme XP-EHH scores
(p,0.01). Clusters of highly significant FST values when comparing
East Asia to the rest of the world (p,0.01) and significant global
FST values (p,0.05) were also found for these four genes (Table
S5). It is thus probable that the selective pressure has targeted one
of these genes.
Table 2. Results of the XP-CLR test in a 16 kb region centered
on VKORC1 in the seven geographic regions.
Region
Physical
position
XP-CLR
score
XP-CLR
p-valuea
Africa 31005354 0.00 1.000
31009354 0.00 1.000
31013354 0.96 0.289
31017354 0.58 0.348
31021354 0.09 0.470
Middle East 31005354 4.00 0.138
31009354 0.85 0.306
31013354 3.28 0.158
31017354 0.27 0.403
31021354 6.25 0.092
Europe 31005354 0.54 0.351
31009354 0.00 1.000
31013354 2.63 0.186
31017354 0.15 0.427
31021354 2.40 0.198
Central South Asia 31005354 0.03 0.464
31009354 0.00 1.000
31013354 0.00 1.000
31017354 0.01 0.476
31021354 0.00 0.490
East Asia 31005354 24.08 0.032 *
31009354 16.53 0.050 *
31013354 30.49 0.023 *
31017354 26.82 0.028 *
31021354 43.44 0.012 *
Oceania 31005263 0.00 1.000
31009263 0.00 1.000
31013263 0.00 1.000
31017263 0.00 1.000
31021263 0.00 1.000
America 31005354 0.00 1.000
31009354 0.00 1.000
31013354 0.00 1.000
31017354 0.01 0.587
31021354 0.00 0.597
aP-values are derived from the empirical distribution of the XP-CLR scores along
the chromosome 16.
*p,0.05; ** p,0.01; *** p,0.005.
doi:10.1371/journal.pone.0053049.t002
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When did the -1639A VKORC1 Allele begin to Increase in
East Asia?
The time at which the frequency of the -1639A allele started to
increase in East Asia was estimated by using a maximum-
likelihood method [31] with the 17 East Asian HGDP-CEPH
sample data. Our analysis yielded an age estimate of 181
generations (95% CI: 128–256 generations). Assuming a genera-
tion time of 25 years, the expansion therefore occurred about
4,525 years ago (95% CI: 3,200–6,400 years).
Discussion
Numerous genes involved in absorption, distribution, metabo-
lism and excretion (ADME) of drugs, exhibit evidence of recent
positive selection and/or high population differentiation levels
[32]. However, there are fewer examples of the action of natural
selection on genes involved in the pharmacodynamics of drugs,
such as VKORC1. Although numerous surveys have examined the
genetic polymorphism of VKORC1 in samples from diverse ethnic
origins [13,20,33,34,35,36,37], these studies provided an incom-
plete picture of haplotype diversity because different sets of SNPs
were used and worldwide coverage was incomplete. In this study,
we took advantage of the worldwide coverage of the HGDP-
CEPH Panel to provide the first detailed analysis of VKORC1
population diversity using the same set of SNPs. Haplotype
analysis revealed that the -1639A derived allele that confers AVK
sensitivity is carried by a unique haplotype in all 52 population
samples investigated. This haplotype associated with AVK
sensitivity is predominant in East Asia, rare in Sub-Saharan
Africa and occurs at intermediate frequencies in other geographic
regions. Because it is found in Sub-Saharan Africa and other world
populations, this haplotype is probably rather old. Its geographic
distribution leads to striking differences between East Asian and
non East Asian samples for genetic susceptibility to AVK
sensitivity.
One explanation for worldwide diversity of this haplotype could
be positive selection. This hypothesis was supported by five
genome-wide scans that found atypical patterns of the allele
frequency spectrum [38], extended LD [39,40], and unusual
genetic differentiation [40,41,42] in a 450 kb genomic region
encompassing VKORC1. When specified, the target population was
Asian [38,40]. Ross et al. [14] found evidence of positive selection
at VKORC1 in the East Asian HapMap sample, based on the level
of genetic diversity (lnRH test [17]), genetic differentiation (LSBL
test [16]) and allele frequency spectrum (Tajima’s D [18]).
Figure 2. Atypical patterns of genetic differentiation observed for VKORC1 SNPs. Genome-wide empirical distributions of FST values were
constructed from 644,143 SNPs having a MAF $0.001 at the global level. Individual values of FST calculated for each of the seven VKORC1 SNPs are
plotted against their global MAF. The functional rs9923231 SNP is shown in red. The 50th, 95th and 99th percentiles are indicated as dotted, dashed
and full red lines, respectively.
doi:10.1371/journal.pone.0053049.g002
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In this study, we provided compelling evidence of positive
selection at the VKORC1 gene locus in East Asia and only in this
geographic region. A footprint of natural selection was found in
each of the widely distributed 17 HGDP-CEPH East Asian
population samples. By using four different tests of positive
selection and by assessing significance at a given locus on the basis
of an empirical distribution derived from the genomic background,
we believe we can be confident that positive selection, rather than
demographic forces, accounts for the data presented here. Indeed,
it is well known that large allele frequency differences between
populations are not infallible proofs of positive selection: these can
also result from genetic drift, migration and other neutral
demographic processes [43,44]. This might be the explanation
for the significant inter-regional FST values observed in Central
South Asia (Table 1 and Figure 2B).
Because the XP-EHH test is designed to detect fixation events
that are relatively young (, 30,000 years) [27], the selective event
we have detected is likely to be rather recent. This is indeed
supported by an age estimate of 4,525 years (95% CI: 3,200–6,400
years) for the time at which the VKORC1 -1639A allele started to
increase in frequency in East Asia. The poor performance of the
iHS test that detected only very few signals of positive selection in
this study could have been predicted since its power to detect
selective sweeps involving alleles near fixation is known to be low
[28,45]. By contrast, XP-EHH and XP-CLR perform better when
the allele targeted by selection is near fixation and indeed showed
strong evidence of a selective sweep in this study [24,27].
In an attempt to determine if the VKORC1 gene has been the
direct target of positive selection or if it reflects genetic hitchhiking
[23], we extended our analysis to a 2 Mb region surrounding the
VKORC1 gene (Figure 3). Apart from the highly significant
footprint of positive selection localized in the VKORC1 region,
two other significant signals, at , 570 kb downstream and ,
230 kb upstream of VKORC1, were detected with XP-CLR and/or
XP-EHH in East Asia. These two regions contains genes that
belong to the same integrin family – specifically to the CD11 gene
cluster: ITGAL downstream, and adjoining genes ITGAM and
ITGAX upstream – involved in immune functions and being thus
good candidates for positive selection [46,47,48]. However, since
SNPs located in these integrin genes show limited LD with those of
VKORC1, a single adaptive event is unlikely. Apart from East Asia,
the ITGAL region showed signals of positive selection in other
Figure 3. Distribution of –log10 (p-values) for four selection tests across a 2 Mb region centered on VKORC1. A black vertical line
indicates the physical position of VKORC1 on chromosome 16. Horizontal red dotted and dashed lines show 0.05 and 0.01 chromosome-wide
significance levels, respectively. The selection tests (inter-regional FST, XP-CLR, XP-EHH and iHS, respectively) were separately applied in each of the
seven geographic regions.
doi:10.1371/journal.pone.0053049.g003
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Figure 4. Detailed analysis of a 1.1 Mb genomic region surrounding the VKORC1 gene locus in East Asia. The boundaries of the region
displayed (chr16:30,271,572-31,391,123; UCSC human genome build hg18) were chosen so as to include the three clusters of significant scores
detected in East Asia by the selection tests in the 2 Mb region centered on VKORC1 (Figure 3). (A) Name and location of genes. Exons are
displayed as blue boxes and the transcribed strand is indicated with an arrow. Genes located in the block of strong LD encompassing VKORC1 and
including the SNPs in the red box shown in Figure 4C, are highlighted in the grey area. (B) XP-EHH results in East Asia. The significance of the XP-
EHH scores (2log10 empirical p-value) are shown for individual SNPs with a MAF $0.01 in East Asia. Horizontal dashed lines indicate 0.05 and 0.01
chromosome-wide significance levels. Recombination hotspots detected in HapMap Phase II data are indicated by red vertical dotted lines. The data
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geographic regions (America with XP-CLR, and Sub-Saharan
Africa and Oceania with XP-EHH), arguing for a different
evolutionary history from that of VKORC1, which was only found
in East Asia. This observation emphasizes the need for studying
the geographic distribution of a selective event in a wide range of
genetically diverse populations, as per Scheinfeldt et al. [49] who,
after performing a detailed analysis of a 3 Mb region surrounding
a gene showing strong footprints of positive selection, discovered
patterns of genetic variation consistent with the presence of a
cluster of three independent selective events occurring in different
populations. By extending their analysis to the entire genome, they
identified several other genomic regions exhibiting evidence for
the presence of multiple and independent selective targets,
suggesting that clusters of adaptive evolution, such as the one
detected herein, are widespread in the human genome.
After delimitating the selective signal for VKORC1 by analyzing
selective events identified in the 2 Mb region just described, we
aimed at precisely mapping the gene targeted by positive selection.
VKORC1 is located in a , 505 kb LD block in East Asia
containing 25 genes (Figure 4), and the selective pressure could
have targeted any gene in this LD block. We used FST, XP-CLR
and XP-EHH scores to spatially localize possible targets of positive
selection within the LD region. A block of four adjacent genes –
VKORC1, BCKDK, MYST1, and PRSS8– was found to be the most
likely selective target (Table S4).
BCKDK codes for the mitochondrial branched chain ketoacid
dehydrogenase kinase. MYST1 and PRSS8 are two immunity-
related genes, listed as candidates for positive selection in several
databases [40,42,50]. If, indeed, one of these three genes is the
target of the selective sweep detected here, it should contain a
functional variant of high frequency in East Asia and we did not
find such a variant in HapMap data.
Assuming that selection has directly targeted the VKORC1 gene,
the advantage would then probably be related to vitamin K
metabolism,vitamin K being the only known substrate of
VKORC1. This vitamin plays a crucial role in the synthesis of
vitamin K-dependent (VKD) proteins, especially blood coagula-
tion factors, which requires VKORC1 activity [51,52]. Large
geographic differences in dietary vitamin K intake, especially in
vitamin K2, exist between human populations, with the highest
plasma levels found in Asian populations, as compared to
Europeans and Africans [53,54]. These differences could be
explained by the wide consumption of fermented soybean food
(natto) - a major source of vitamin K2 - in East Asia [55,56]. It is
then possible that, at some points in the history of East Asian
populations, these high levels of vitamin K intakecould have been
deleterious and created a selective pressure against VKORC1 gene
expression and coagulant activity. There is, however, no report so
far of a deleterious effect associated with a high consumption of
vitamin K and it is more the low dietary vitamin K intake that is
problematic, hampering the adequate synthesis of VKD proteins
in extrahepatic tissues notably bone and arterial vessels [57]. An
alternative hypothesis could be that a naturally occurring
environmental molecule of AVK type - such as a coumarin
derivative - specifically found in East Asia, exerted a selective
pressure on the VKORC1 gene in populations of this region during
their recent history. Such molecules are present in the nature, as
illustrated by the example of the sweet clover disease that affected
cattle in Canada and North America in the 1920’s. Sweet clover
hay, used to feed cattle, contains a natural coumarin that is
oxidized in mouldy hay to form dicoumarol, a hemorrhagic agent.
Its discovery led to the synthesis of coumarin derivatives used in
clinical application as oral anticoagulants since the 1940’s [58,59].
Evidence of an effect of warfarin in shaping VKORC1 genetic
diversity could be found in rats and mices. Indeed, since the
introduction in the 1950’s of this molecule as rodenticide,
mutations in the VKORC1 gene conferring warfarin resistance
have spread in rodent populations but the mechanisms by which
they lead to warfarin resistance are still not elucidated
[60,61,62,63].
In conclusion, we found that the VKORC1 genomic region
exhibits diversity patterns consistent with the action of positive
selection in East Asia. Nearly complete selective sweeps, such as
the one described herein, are believed to be rare in recent human
adaptive history [64,65,66,67]. This selective event is probably
responsible for the spread of the derived -1639A allele conferring
the increased AVK-sensitive phenotype in East Asian populations
and contributes to present-day differences among human popu-
lations in the genetic sensitivity to AVK. A detailed analysis of the
extended VKORC1 genomic region revealed selective signals at
several independent genetic loci, indicating a complex evolution-
ary history for this chromosome 16 region. Our evolutionary
analysis emphasizes the importance of considering the surrounding
genomic region of a candidate gene for selection in order to avoid
erroneous conclusions about the true target of selection. We show
here that the gene targeted by selection could be either VKORC1 or
another gene located in the 45 kb region covered by selective
sweep detected in East Asia. Our ability to identify the target of
selection may be limited by the number of genetic polymorphisms
investigated. Examining the selective signal with more genetic
variation using whole-genome sequences from the 1000 Genomes
Project [68] may well improve the mapping of the gene targeted
by selection. Furthermore, allele frequency spectrum bias tends to
be minimized with whole genome sequences, which may allow the
use of tests for natural selection based on this spectrum.
Materials and Methods
The HGDP-CEPH Panel
We used the HGDP-CEPH Panel that presently includes 1,064
individuals from 52 populations worldwide [69]. For the analysis
presented here, the standardized subset panel H952 containing no
first nor second degree relative pairs, was used [70]. This subpanel
includes 952 individuals grouped into seven broad geographic
regions as defined by Li et al. [15]: Sub-Saharan Africa (N= 105),
the Middle East and Mozabites from north Africa (N= 163),
Europe (N= 158), Central South Asia (N= 202), East Asia
(N= 232), Oceania (N=28) and America (N=64). A full
description of the 52 samples included in the HGDP-CEPH
Panel is provided in Table S6.
SNP Genotyping
A total of 940 individuals from the original H952 subpanel were
previously genotyped by Li et al. [15] with the Illumina
HumanHap 650 K platform and their genotypes at 644,258
autosomal SNPs were downloaded from the public HGDP-CEPH
and methods used to derive these hotspots are available from the HapMap website (http://www.hapmap.org/) [83,84]. (C) LD plot. Pairwise LD
values, depicted as D’, are shown for SNPs with a MAF $0.01 in East Asia. D’ values are displayed in different colors from yellow to red for D’ = 0 to
D’ = 1, respectively. The red box highlights SNPs included in the LD block encompassing VKORC1. The plot was produced using the snp.plotter R
package [74].
doi:10.1371/journal.pone.0053049.g004
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database (http://www.cephb.fr/en/hgdp/). Only one SNP
(rs7294) from this dataset is located in the VKORC1 gene. We
additionally genotyped six SNPs in VKORC1 in the 940
individuals, using the TaqManH SNP Genotyping Assay-by-
Design method in 5 ml reaction volumes according to the
manufacturer’s protocol (Applied Biosystems, Foster City, CA):
rs9923231 (g.-1639G.A) located in the promoter region,
rs13336384 and rs9934438 in the first intron, rs2359612 and
rs8050894 in the second intron, and rs7200749 in the third exon
(Figure 1A). Missing genotype rates varied from 0.5% to 2.2% for
SNPs rs7200749 and rs9934438, respectively. Since the two SNPs
rs9923231 and rs9934438 were found in complete LD in the seven
geographic regions (Figure S2), we were able to impute the missing
genotypes of a given SNP using available information from the
other, leading to a total of 0.96% missing genotypes for these two
SNPs. No significant deviations from the Hardy-Weinberg
proportions were observed for any VKORC1 SNP in any of the
52 population samples at the 0.01 significance level (data not
shown). Allele frequency distributions of the seven VKORC1 SNPs
in the 52 population samples are shown in Figure S6.
Statistical Analysis
VKORC1 haplotype study. To investigate the worldwide
diversity of the VKORC1 gene, we conducted a haplotype study
using the seven genotyped SNPs. A total of 931 individuals with
less than three missing genotypes were included in the haplotype
reconstruction. For each geographic region, haplotype frequencies
were estimated with the Bayesian statistical method implemented
in Phase v2.1 [71] using defaults parameters. To avoid the
convergence of the algorithm to a local maximum, we ran it 10
times with different random seeds and kept the output from the
run with the best average value. The worldwide haplotype
frequencies were then calculated as the weighted average of the
frequencies estimated in each of the seven geographic regions.
Similar results were obtained when a single pooled sample of all
individuals was considered in the haplotype frequency estimation
(data not shown). Since information on ancestral allele state is
required to distinguish between ancestral and derived haplotypes,
we used the snp131OrthoPt2Pa2Rm2.txt file downloaded from
the UCSC genome browser (http://genome.ucsc.edu/) which
provides the orthologous alleles in chimpanzee, orangutan and
rhesus macaque. For each SNP, the allele shared by the three
species was identified as the ancestral allele. Haplotype networks
were drawn with the Network v4.5.1.6 software (http://www.
fluxus-engineering.com/), using the median-joining algorithm
which builds the minimum spanning network from the given
haplotypes by favoring short connections [72]. LD analyses were
performed with Haploview v4.1 [73] and the snp.plotter R
package [74], using Lewontin’s disequilibrium coefficient D’ [75]
and the correlation coefficient r2 [76].
Detection of Signatures of Positive Selection
To explore whether VKORC1 has evolved under positive
selection in humans, we looked for two distinct genetic patterns
of a selective sweep that are expected to remain detectable in the
genome over different time scales after the action of natural
selection: (i) an important genetic differentiation among popula-
tions nearby the locus of interest, and (ii) the presence of unusually
frequent and long haplotypes in the surrounding genomic region.
For each method, we used an outlier approach to calculate the p-
values of the computed scores. Under this approach, an empirical
distribution is constructed using other SNPs in the genome that
are assumed to be neutral and to represent the genomic
background under neutrality. An empirical p-value is computed
that corresponds to the proportion of values from the empirical
distribution that are higher than the value observed at the locus of
interest. If the value obtained for the SNP of interest is greater
than the 95th percentile (p,0.05) of the empirical distribution,
positive selection is invoked. For that purpose, we used the
empirical distributions obtained from the scores calculated either
on a genome-wide (all autosomal chromosomes) or chromosome-
wide (chromosome 16, where VKORC1 is located) basis.
First, we used two statistics, FST and XP-CLR, which measure
the genetic differentiation among human populations [24,26].
These methods are able to detect selective sweeps that have
occurred up to 75,000 years ago [77]. The fixation index FST [78]
quantifies the proportion of genetic variance explained by allele
frequency differences among populations. FST ranges from 0 (for
genetically identical populations) to 1 (for completely differentiated
populations). We calculated FST values using the BioPerl module
PopGen [79] for each autosomal SNP with a minor allele
frequency (MAF) $1023 (644,143 SNPs) at three different levels:
(i) global level (either among the seven HGDP-CEPH Panel
geographic regions or among the 52 Panel populations), (ii) inter-
regional level (each geographic region versus the remaining ones),
and (iii) intra-regional level (among populations within a region).
Since FST strongly correlates with heterozygosity [41,80,81],
empirical p-values were calculated within bins of 10,000 SNPs
grouped according to MAF. The resulting distributions represent
the average genetic differentiation of human populations corrected
for heterozygosity.
We next applied the XP-CLR test [24] which identifies selective
sweeps in a population by detecting significant genetic differen-
tiation in an extended genomic region of interest as compared to a
reference population. This method presents both the advantages of
being robust to ascertainment bias and of not requiring any
information on haplotypes, thus avoiding errors of haplotype
estimation from genotype data. XP-CLR scores were computed at
regularly spaced grid points (every 4 kb) across chromosome 16
using the genotypes from SNPs within overlapping windows of
0.1 cM around each grid point. To account for different SNP
densities among genomic regions, we restricted to 200 the
maximal number of SNPs used to compute a XP-CLR score
within the 0.1 cM genomic region, by removing excess SNPs at
random. We applied this method by considering all SNPs with a
MAF $1023 on chromosome 16 at both the regional and
population levels (17,729 SNPs). P-values were calculated from the
empirical distribution of the collected scores obtained with these
SNPs. XP-CLR requires the definition of a reference population:
the Sub-Saharan African samples were used as a reference for non
Sub-Saharan African regions, and the European samples as a
reference for Sub-Saharan Africa. For the analyses performed at
the population level, we defined the Yoruba as the reference for
non Sub-Saharan African samples, and the French for Sub-
Saharan African samples.
The second class of methods that we used is based on EHH, i.e.
the sharing of identical alleles across relatively long distances by
most haplotypes in population samples [25]. In brief, the EHH is
computed for a given SNP (the core SNP) of a sequence being
interrogated for a selective sweep. In the absence of a selective
sweep, recombination events break down haplotypes relatively
rapidly with time and with increasing distance from the core SNP.
In the case of a selective sweep, LD tends to maintain the
haplotype carrying the selected allele, and the relative frequency of
this (favored) haplotype will increase with time leading to so-called
EHH. Integration of genetic distance in both directions from the
core SNP can be used to discriminate between selected and non-
selected alleles, and be applied to ancestral and derived alleles.
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Analytic methods based on EHH are able to detect recent selective
sweeps (i.e. those occurring less than 30,000 years ago [77]). Such
analyses require haplotype data. We used fastPHASE v1.3.0 EM
algorithm [82] to infer haplotypes with chromosome 16 SNPs for
individuals from each geographic region. For each region, the K-
selection procedure was first run several times in order to define
the optimal number of clusters of similar haplotypes by minimizing
chance error rates. Ultimately, phase was determined with K=6
for Oceania, K=14 for Europe and Central-South Asia and
K=12 for the remaining regions. Using these values, the EM
algorithm was then run with 20 random starts and 25 iterations.
Once haplotypes were reconstructed, we computed the XP-
EHH statistic [27] that compares the integrated EHH
computed in a test population versus that of a reference
population. Therefore, this method detects a sweep in which
the selected allele has risen to near fixation in one population
but remains polymorphic in the other. XP-EHH scores were
computed using the same parameters as those described in
Sabeti et al. (2007). Reference populations were defined as for
XP-CLR.
We finally applied the iHS [28] that compares the rate of EHH
decay observed for both the derived and ancestral allele at the core
SNP. An extremely positive or negative value at the core SNP
provides evidence of positive selection with unusually long
haplotypes carrying the ancestral or the derived allele, respectively.
The raw iHS scores were computed using the iHS option
implemented in the WHAMM software developed by Voight
et al. (2006). The scores were standardized to have null mean and
unit variance in 5% bins of the derived allele frequency at the core
SNP. Information on ancestral allele state was obtained from the
snp131OrthoPt2Pa2Rm2.txt file downloaded from the UCSC
website. We were unable to determine with certainty the ancestral
allele status of 111 SNPs on chromosome 16 and we removed
them from the analysis.
XP-EHH and iHS scores were calculated for all available SNPs
on chromosome 16 (19,733 and 19,622, respectively) at both the
regional and population levels. The resulting distributions were
used to calculate empirical p-values.
The genetic map used for applying XP-CLR, XP-EHH and
iHS was retrieved from release 22, build 36 of HapMap (www.
hapmap.org).
Age of the Expansion of the -1639A VKORC1 Allele in East
Asia
We inferred the age at which the -1639A allele started to
increase in frequency in East Asia by estimating the age of the
most recent common ancestor carrying this allele in East Asia
using the likelihood-based method implemented in the Estiage
program [31]. This method assumes that all individuals derive
from a common ancestor who introduced the mutation n
generations ago. Estimation of n is based on the length of the
haplotype shared by the individuals, which is estimated
through the identification of recombination events on the
ancestral haplotype by taking into account allele frequencies
and recombination rates. We estimated n using only one
haplotype per East Asian population sample (i.e., 17 haplo-
types). For each population, this one haplotype was construct-
ed by taking at each locus over a 6 Mb region the allele the
most frequently seen in individuals from the population
carrying the -1639A allele. A mutation rate of 1026 per
individual and per generation, and a 25-year generation time
were assumed.
Supporting Information
Figure S1 Distribution of VKORC1 haplotypes in the 52
HGDP-CEPH samples. The haplotype carrying the -1639A
allele (H1) is represented in red and the ancestral haplotype (H6) in
black.
(TIF)
Figure S2 Pairwise LD between the seven VKORC1
SNPs at the regional and global level. Red squares indicate
statistically significant (logarithm of odds .2) LD between the pair
of SNPs, as measured by the D’ statistic [75] with the Haploview
software [73]; darker colors of red indicate higher values of D’, up
to a maximum of 1. White squares indicate pairwise D’ values of
,1 with no statistically significant evidence of LD. Blue squares
indicate pairwise D’ values of 1 but without statistical significance.
(TIF)
Figure S3 Genome-wide empirical distributions of
inter-regional FST values against MAF in the seven
geographic regions. Empirical distributions of FST were
constructed by calculating an FST value for 644,413 SNPs having
a MAF $0.001 at the global level. Individual values of FST
calculated for each of the seven VKORC1 SNPs are plotted against
their global MAF. The functional rs9923231 SNP is shown in red.
The 50th, 95th and 99th percentiles are indicated as dotted, dashed
and full red lines, respectively.
(TIFF)
Figure S4 Genome-wide empirical distributions of in-
tra-regional FST values against MAF in the seven
geographic regions. Empirical distributions of FST were
constructed by calculating an FST value for all SNPs having a
MAF $0.001 at the intra-regional level. Individual values of FST
calculated for each of the seven VKORC1 SNPs are plotted against
the regional MAF. The functional rs9923231 SNP is shown in red.
The 50th, 95th and 99th percentiles are indicated as dotted, dashed
and full red lines, respectively.
(TIFF)
Figure S5 LD patterns over a 2 Mb region centered on
VKORC1 in the seven geographic regions. Pairwise LD,
depicted as D’, is shown for SNPs with a MAF $0.05 at the global
level. D’ values are displayed in different colors from yellow to red
for D’ = 0 to D’ = 1, respectively. The plot was produced using the
snp.plotter R package [74]. The vertical dashed lines delineate
VKORC1 gene position.
(TIF)
Figure S6 Allele frequency distribution of the seven
VKORC1 SNPs in the 52 HGDP-CEPH samples: rs9923231
(A), rs13336384, (B) rs9934438 (C), rs8050894 (D), rs2359612
(E), rs7200749 (F) and rs7294 (G). The derived and ancestral
alleles are represented in orange and blue, respectively.
(TIF)
Table S1 Global FST values among populations and among
regions for the seven VKORC1 SNPs.
(XLS)
Table S2 Results of the XP-CLR test in a 16 kb region centered
on VKORC1 in the 52 HGDP-CEPH samples.
(XLS)
Table S3 Results of the XP-EHH and iHS tests in the 52
HGDP-CEPH samples.
(XLS)
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Table S4 Results of the XP-CLR test in the , 500 kb genomic
region of the LD block encompassing VKORC1 in East Asia.
(XLS)
Table S5 Results of the XP-EHH, iHS tests, inter-regional FST
and global FST for all SNPs located in the linkage disequilibrium
block encompassing VKORC1 in East Asia.
(XLS)
Table S6 Description of the 52 HGDP-CEPH samples grouped
into seven main geographic regions.
(XLS)
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